Cargando…
Pursuing use of optimal formulations for paediatric HIV epidemic control – a look at the use of LPV/r oral pellets and oral granules
INTRODUCTION: Despite a significant reduction in mother‐to‐child transmission of HIV, an estimated 180,000 children were infected with HIV in 2017, and only 52% of children under 15 years of age living with HIV (CLHIV) are on life‐saving antiretroviral therapy (ART). Without effective treatment, hal...
Autores principales: | Malati, Christine Y, Golin, Rachel, O'Brien, Lisa, Sugandhi, Nandita, Srivastava, Meena, Larson, Chris, Phelps, Benjamin R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462808/ https://www.ncbi.nlm.nih.gov/pubmed/30983152 http://dx.doi.org/10.1002/jia2.25267 |
Ejemplares similares
-
Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation
por: Nebot Giralt, Ariadna, et al.
Publicado: (2017) -
Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation
por: Nebot Giralt, Ariadna, et al.
Publicado: (2019) -
The promise of paediatric dolutegravir
por: Golin, Rachel, et al.
Publicado: (2021) -
CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily
por: Tiraboschi, Juan, et al.
Publicado: (2014) -
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
por: Deng, Lisi, et al.
Publicado: (2020)